Biogen Message Board - Msg: 7029029

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen

BIIB 155.13

-0.2%

10:56 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bwe who wrote (820)	12/30/1998 10:43:00 AM
From: Harold Engstrom	Read Replies (1) of 1686

Thanks, Bruce. Earnings will be out in a week or so. The consensus is $0.54, but I agree with V1 that there should be some upside - firstly, there has been another sizeable increase in the number of patients taking Avonex, and secondly, there should be higher royalty income recognized. The increased number of patients should allow Biogen to meet or slightly exceed the estimate. If royalties have been recorded conservatively as stated early this quarter, then there should be a decent upside. I'll take a stab and say $0.57. It could be slightly higher, but Biogen will probably defer some earning if they can in order to manage earnings growth.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next